Health Idea Now: India’s drug regulator expects to finalize new clinical trial rules in two months

MUMBAI (Reuters) - India’s drug regulator plans to finalize new rules for clinical trials in a couple of months that would shorten the review time, a senior official said on Wednesday, aiming to boost clinical research in the country after interest in recent years waned.